Saccharomyces cerevisiae-based probiotic as novel anti-fungal and anti-inflammatory agent for therapy of vaginal candidiasis.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Beneficial Microbes

• Publication date

  2018-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3920/BM2017.0099PMID 29380641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Getting to the heart of the matter: Role of Streptococcus mutans adhesin Cnm in systemic disease

  2017cited by this paper
• Effect in virulence of switching conserved homologous capsular polysaccharide genes from Klebsiella pneumoniae serotype K1 into K20

  2017cited by this paper
• Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis

  2017cited by this paper
• In vivo induction of neutrophil chemotaxis by secretory aspartyl proteinases of Candida albicans

  2016influential reference
• Aspartyl Proteinases of Eukaryotic Microbial Pathogens: From Eating to Heating

  2016cited by this paper
• Candidalysin is a fungal peptide toxin critical for mucosal infection

  2016cited by this paper
• Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota

  2016cited by this paper
• Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis

  2016influential reference
• Induction of Caspase-11 by Aspartyl Proteinases of Candida albicans and Implication in Promoting Inflammatory Response

  2015cited by this paper
• A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome.

  2015cited by this paper
• Experimental models of vaginal candidiasis and inflammation.

  2015cited by this paper
• Saccharomyces cerevisiae CNCM I-3856 Prevents Colitis Induced by AIEC Bacteria in the Transgenic Mouse Model Mimicking Crohn's Disease

  2015cited by this paper
• Saccharomyces cerevisiae EC-1118 enhances the survivability of probiotic Lactobacillus rhamnosus HN001 in an acidic environment

  2015cited by this paper
• Secretory Aspartyl Proteinases Cause Vaginitis and Can Mediate Vaginitis Caused by Candida albicans in Mice

  2015influential reference
• Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation

  2015cited by this paper
• Irritable bowel syndrome: a microbiome-gut-brain axis disorder?

  2014cited by this paper
• Saccharomyces boulardii Modifies Salmonella Typhimurium Traffic and Host Immune Responses along the Intestinal Tract

  2014cited by this paper
• Candida Vaginitis: When Opportunism Knocks, the Host Responds

  2014cited by this paper
• Involvement of IL-17A in preventing the development of deep-seated candidiasis from oropharyngeal infection.

  2014cited by this paper
• Candida albicans Pathogenicity and Epithelial Immunity

  2014cited by this paper
• Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice.

  2013cited by this paper
• Effect of pressure support vs unassisted breathing through a tracheostomy collar on weaning duration in patients requiring prolonged mechanical ventilation: a randomized trial.

  2013cited by this paper
• Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome

  2013cited by this paper
• S-Adenosyl-L-Methionine protects the probiotic yeast, Saccharomyces boulardii, from acid-induced cell death

  2013cited by this paper
• Host-Gut Microbiota Metabolic Interactions

  2012cited by this paper
• Functional interactions between the gut microbiota and host metabolism

  2012cited by this paper
• β-Galactomannan and Saccharomyces cerevisiae var. boulardii Modulate the Immune Response against Salmonella enterica Serovar Typhimurium in Porcine Intestinal Epithelial and Dendritic Cells

  2012cited by this paper
• Th17 Cells and IL-17 in Protective Immunity to Vaginal Candidiasis

  2011cited by this paper
• Genetic control of Candida albicans biofilm development

  2011cited by this paper
• Candida albicans interactions with epithelial cells and mucosal immunity.

  2011cited by this paper
• From Attachment to Damage: Defined Genes of Candida albicans Mediate Adhesion, Invasion and Damage during Interaction with Oral Epithelial Cells

  2011cited by this paper
• Growth of Candida albicans hyphae

  2011cited by this paper
• Probiotics

  2009cited by this paper
• Prebiotics in Chronic Intestinal Inflammation

  2009cited by this paper
• Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system.

  2009cited by this paper
• Comparative study of Bifidobacteriumanimalis, Escherichiacoli, Lactobacilluscasei and Saccharomycesboulardii probiotic properties

  2009cited by this paper
• Effect of Probiotics on Intestinal Barrier Function

  2009cited by this paper
• Generation of epidermal growth factor-expressing Lactococcus lactis and its enhancement on intestinal development and growth of early-weaned mice.

  2009cited by this paper
• Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis.

  2008cited by this paper
• Genotypic and Physiological Characterization of Saccharomyces boulardii, the Probiotic Strain of Saccharomyces cerevisiae

  2007cited by this paper
• Recognition of microorganisms and activation of the immune response

  2007cited by this paper
• Candida albicans HWP1 gene expression and host antibody responses in colonization and disease.

  2006cited by this paper
• Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression.

  2006cited by this paper
• Saccharomyces boulardii prevents TNF-alpha-induced apoptosis in EHEC-infected T84 cells.

  2006cited by this paper
• Saccharomyces boulardii prevents TNF-α-induced apoptosis in EHEC-infected T84 cells

  2006cited by this paper
• Probiotic therapy of intestinal inflammation and infections

  2005cited by this paper
• Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes.

  2003influential reference
• Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis.

  2002cited by this paper
• Identification and phylogeny of ascomycetous yeasts from analysis of nuclear large subunit (26S) ribosomal DNA partial sequences

  1998influential reference
• Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5' end of the large-subunit (26S) ribosomal DNA gene

  1997influential reference
• Dynamics of differentiation in human epidermoid squamous carcinoma cells (A431) with continuous, long-term γ-IFN treatment

  1991influential reference
• Evidence for macrophage-mediated protection against lethal Candida albicans infection

  1986cited by this paper
• [Routes of administration].

  1954influential reference
• Rev. Latino-am. Enfermagem How to Cite This Article the Impact of the Use of Different Types of Gloves and Bare Hands for Preparation of Clean Surgical Instruments 1

  year unknowncited by this paper

• Probiotic‐Based Materials as Living Therapeutics

  2025cites this paper
• The Biotherapeutic Potential of a Novel Probiotic Kluyveromyces marxianus Isolated from a Sourdough Starter Against Vaginal Candida albicans Strains

  2025cites this paper
• Vaginal microbiota: Potential targets for vulvovaginal candidiasis infection

  2024cites this paper
• Establishment of an in vitro evaluation method for immunomodulatory functions of yeast strains

  2024cites this paper
• Bacillus coagulans LMG S-24828 Impairs Candida Virulence and Protects Vaginal Epithelial Cells against Candida Infection In Vitro

  2024cites this paper
• Antioxidant and anti-inflammatory properties of water kefir microbiota and its bioactive metabolites for health promoting bio-functional products and applications

  2024cites this paper
• Evaluation of the Efficacy of Medicinal Plants in Treating Bacterial Vaginosis: A Comprehensive Systematic Review of Interventional Studies

  2024cites this paper
• Silver secnidazole nano‐hybrid emulsion‐based probiotics as a novel antifungal formula against multidrug‐resistant vaginal pathogens

  2024cites this paper
• The Hygienic Significance of Microbiota and Probiotics for Human Wellbeing

  2024cites this paper
• The Interplay between Candida albicans, Vaginal Mucosa, Host Immunity and Resident Microbiota in Health and Disease: An Overview and Future Perspectives

  2023cites this paper
• Saccharomyces cerevisiae: Multifaceted Applications in One Health and the Achievement of Sustainable Development Goals

  2023cites this paper
• Probiotics in vaginal health.

  2023cites this paper
• Skincare potential of a sustainable postbiotic extract produced through sugarcane straw fermentation by Saccharomyces cerevisiae

  2023cites this paper
• Probiotics and their postbiotics for the control of opportunistic fungal pathogens: A review

  2023cites this paper
• Impacts of Menstruation, Community Type, and an Oral Yeast Probiotic on the Vaginal Microbiome

  2022cites this paper
• Can the Therapeutic Spectrum of Probiotics be Extended: Exploring Potential of Gut Microbiome.

  2022cites this paper
• Biovalorization of Market Surplus Bread for Development of Probiotic-Fermented Potential Functional Beverages

  2022cites this paper
• Probiotics and Postbiotics from Food to Health: Antimicrobial Experimental Confirmation

  2021cites this paper
• Postbiotics: defining the impact of inactivated microbes and their metabolites on promotion of health

  2021cites this paper
• Application of probiotics in candidiasis management

  2021cites this paper
• Drops of Lactiplantibacillus plantarum CRL 759 culture supernatant attenuates eyes inflammation induced by lipopolysaccharide.

  2021cites this paper
• The Role of Fatty Acid Metabolites in Vaginal Health and Disease: Application to Candidiasis

  2021influential citation
• Saccharomyces and Their Potential Applications in Food and Food Processing Industries

  2021cites this paper
• Probiotics in gynaecology

  2020cites this paper
• Yeast extract demonstrates rapid itch relief in chronic pruritus

  2020cites this paper
• Applying the Host-Microbe Damage Response Framework to Candida Pathogenesis: Current and Prospective Strategies to Reduce Damage

  2020cites this paper
• Saccharomyces cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections

  2020influential citation
• Probiotika v gynekologii

  2020cites this paper
• Recovery of Saccharomyces cerevisiae CNCM I-3856 in Vaginal Samples of Healthy Women after Oral Administration

  2020cites this paper
• Lactobacillus rhamnosus cell free extract targets virulence and antifungal drug resistance in Candida albicans.

  2020cites this paper
• Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of Candida albicans

  2020cites this paper
• Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis

  2020cites this paper
• Pathogenesis and Clinical Relevance of Candida Biofilms in Vulvovaginal Candidiasis

  2020cites this paper
• Probiotics as antifungal agents: Experimental confirmation and future prospects.

  2019cites this paper
• Probiotics and prebiotics potential for the care of skin, female urogenital tract, and respiratory tract

  2019cites this paper
• Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis

  2019cites this paper